Skip to main content

2 Result(s)

within Ning Li MD Remove this filter Medicine & Public Health Remove this filter Surgical Oncology Remove this filter

and

  1. Article

    Open Access

    Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy

    Gastric cancer (GC) remains one of the world’s most common and fatal malignant tumors. With a refined understanding of molecular ty** in recent years, microsatellite instability (MSI) has become a major mole...

    Hui Wu MSc, Wenyuan Ma BSc, Congfa Jiang MD, Ning Li MD… in Annals of Surgical Oncology (2023)

    Download PDF (649 KB) View Article

  2. No Access

    Article

    Pemetrexed-Carboplatin Adjuvant Chemotherapy With or Without Gefitinib in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Harbouring EGFR Mutations: A Randomized, Phase II Study

    Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) show great efficacy in patients with advanced non-small cell lung cancer (NSCLC) with EGFR mutations. The efficacy and safety of gefitini...

    Ning Li MD, Wei Ou MD, **ong Ye MD, Hai-Bo Sun MD… in Annals of Surgical Oncology (2014)